China Atorvastatin Calcium Market Report & Forecast 2021-2027

China Atorvastatin Calcium Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Atorvastatin Calcium Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 China Atorvastatin Calcium Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 China Atorvastatin Calcium Overall Market Size
2.1 China Atorvastatin Calcium Market Size: 2021 VS 2027
2.2 China Atorvastatin Calcium Revenue, Prospects & Forecasts: 2016-2027
2.3 China Atorvastatin Calcium Sales: 2016-2027
3 Company Landscape
3.1 Top Atorvastatin Calcium Players in China Market
3.2 Top China Atorvastatin Calcium Companies Ranked by Revenue
3.3 China Atorvastatin Calcium Revenue by Companies
3.4 China Atorvastatin Calcium Sales by Companies
3.5 China Atorvastatin Calcium Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Atorvastatin Calcium Companies in China Market, by Revenue in 2020
3.7 Manufacturers Atorvastatin Calcium Product Type
3.8 Tier 1, Tier 2 and Tier 3 Atorvastatin Calcium Players in China Market
3.8.1 List of Tier 1 Atorvastatin Calcium Companies in China
3.8.2 List of Tier 2 and Tier 3 Atorvastatin Calcium Companies in China
4 Sights by Type
4.1 Overview
4.1.1 By Type - China Atorvastatin Calcium Market Size Markets, 2021 & 2027
4.1.2 Chemical Synthesis
4.1.3 Biocatalysis
4.2 By Type - China Atorvastatin Calcium Revenue & Forecasts
4.2.1 By Type - China Atorvastatin Calcium Revenue, 2016-2021
4.2.2 By Type - China Atorvastatin Calcium Revenue, 2022-2027
4.2.3 By Type - China Atorvastatin Calcium Revenue Market Share, 2016-2027
4.3 By Type - China Atorvastatin Calcium Sales & Forecasts
4.3.1 By Type - China Atorvastatin Calcium Sales, 2016-2021
4.3.2 By Type - China Atorvastatin Calcium Sales, 2022-2027
4.3.3 By Type - China Atorvastatin Calcium Sales Market Share, 2016-2027
4.4 By Type - China Atorvastatin Calcium Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - China Atorvastatin Calcium Market Size, 2021 & 2027
5.1.2 Tablet (Including Dispersible Tablet and General Tablet)
5.1.3 Capsule
5.1.4 Others
5.2 By Application - China Atorvastatin Calcium Revenue & Forecasts
5.2.1 By Application - China Atorvastatin Calcium Revenue, 2016-2021
5.2.2 By Application - China Atorvastatin Calcium Revenue, 2022-2027
5.2.3 By Application - China Atorvastatin Calcium Revenue Market Share, 2016-2027
5.3 By Application - China Atorvastatin Calcium Sales & Forecasts
5.3.1 By Application - China Atorvastatin Calcium Sales, 2016-2021
5.3.2 By Application - China Atorvastatin Calcium Sales, 2022-2027
5.3.3 By Application - China Atorvastatin Calcium Sales Market Share, 2016-2027
5.4 By Application - China Atorvastatin Calcium Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Overview
6.1.3 Pfizer Atorvastatin Calcium Sales and Revenue in China Market (2016-2021)
6.1.4 Pfizer Atorvastatin Calcium Product Description
6.1.5 Pfizer Recent Developments
6.2 DSM Sinochem Pharmaceuticals
6.2.1 DSM Sinochem Pharmaceuticals Corporation Information
6.2.2 DSM Sinochem Pharmaceuticals Overview
6.2.3 DSM Sinochem Pharmaceuticals Atorvastatin Calcium Sales and Revenue in China Market (2016-2021)
6.2.4 DSM Sinochem Pharmaceuticals Atorvastatin Calcium Product Description
6.2.5 DSM Sinochem Pharmaceuticals Recent Developments
6.3 Ind-Swift
6.3.1 Ind-Swift Corporation Information
6.3.2 Ind-Swift Overview
6.3.3 Ind-Swift Atorvastatin Calcium Sales and Revenue in China Market (2016-2021)
6.3.4 Ind-Swift Atorvastatin Calcium Product Description
6.3.5 Ind-Swift Recent Developments
6.4 Cadila Pharmaceuticals
6.4.1 Cadila Pharmaceuticals Corporation Information
6.4.2 Cadila Pharmaceuticals Overview
6.4.3 Cadila Pharmaceuticals Atorvastatin Calcium Sales and Revenue in China Market (2016-2021)
6.4.4 Cadila Pharmaceuticals Atorvastatin Calcium Product Description
6.4.5 Cadila Pharmaceuticals Recent Developments
6.5 Morepen
6.5.1 Morepen Corporation Information
6.5.2 Morepen Overview
6.5.3 Morepen Atorvastatin Calcium Sales and Revenue in China Market (2016-2021)
6.5.4 Morepen Atorvastatin Calcium Product Description
6.5.5 Morepen Recent Developments
6.6 Sun Pharmaceutical Industries
6.6.1 Sun Pharmaceutical Industries Corporation Information
6.6.2 Sun Pharmaceutical Industries Overview
6.6.3 Sun Pharmaceutical Industries Atorvastatin Calcium Sales and Revenue in China Market (2016-2021)
6.6.4 Sun Pharmaceutical Industries Atorvastatin Calcium Product Description
6.6.5 Sun Pharmaceutical Industries Recent Developments
6.7 MSN Laboratories
6.7.1 MSN Laboratories Corporation Information
6.7.2 MSN Laboratories Overview
6.7.3 MSN Laboratories Atorvastatin Calcium Sales and Revenue in China Market (2016-2021)
6.7.4 MSN Laboratories Atorvastatin Calcium Product Description
6.7.5 MSN Laboratories Recent Developments
6.8 Dr. Reddy's
6.8.1 Dr. Reddy's Corporation Information
6.8.2 Dr. Reddy's Overview
6.8.3 Dr. Reddy's Atorvastatin Calcium Sales and Revenue in China Market (2016-2021)
6.8.4 Dr. Reddy's Atorvastatin Calcium Product Description
6.8.5 Dr. Reddy's Recent Developments
6.9 Teva Pharmaceutical Industries
6.9.1 Teva Pharmaceutical Industries Corporation Information
6.9.2 Teva Pharmaceutical Industries Overview
6.9.3 Teva Pharmaceutical Industries Atorvastatin Calcium Sales and Revenue in China Market (2016-2021)
6.9.4 Teva Pharmaceutical Industries Atorvastatin Calcium Product Description
6.9.5 Teva Pharmaceutical Industries Recent Developments
6.10 Apotex Pharmachem
6.10.1 Apotex Pharmachem Corporation Information
6.10.2 Apotex Pharmachem Overview
6.10.3 Apotex Pharmachem Atorvastatin Calcium Sales and Revenue in China Market (2016-2021)
6.10.4 Apotex Pharmachem Atorvastatin Calcium Product Description
6.10.5 Apotex Pharmachem Recent Developments
6.11 Zheijang Neo-Dankon Pharmaceutical
6.11.1 Zheijang Neo-Dankon Pharmaceutical Corporation Information
6.11.2 Zheijang Neo-Dankon Pharmaceutical Overview
6.11.3 Zheijang Neo-Dankon Pharmaceutical Atorvastatin Calcium Sales and Revenue in China Market (2016-2021)
6.11.4 Zheijang Neo-Dankon Pharmaceutical Atorvastatin Calcium Product Description
6.11.5 Zheijang Neo-Dankon Pharmaceutical Recent Developments
6.12 Ningbo Menovo Pharmaceuticals Group
6.12.1 Ningbo Menovo Pharmaceuticals Group Corporation Information
6.12.2 Ningbo Menovo Pharmaceuticals Group Overview
6.12.3 Ningbo Menovo Pharmaceuticals Group Atorvastatin Calcium Sales and Revenue in China Market (2016-2021)
6.12.4 Ningbo Menovo Pharmaceuticals Group Atorvastatin Calcium Product Description
6.12.5 Ningbo Menovo Pharmaceuticals Group Recent Developments
6.13 Jialin Pharmaceutical
6.13.1 Jialin Pharmaceutical Corporation Information
6.13.2 Jialin Pharmaceutical Overview
6.13.3 Jialin Pharmaceutical Atorvastatin Calcium Sales and Revenue in China Market (2016-2021)
6.13.4 Jialin Pharmaceutical Atorvastatin Calcium Product Description
6.13.5 Jialin Pharmaceutical Recent Developments
6.14 Topfond
6.14.1 Topfond Corporation Information
6.14.2 Topfond Overview
6.14.3 Topfond Atorvastatin Calcium Sales and Revenue in China Market (2016-2021)
6.14.4 Topfond Atorvastatin Calcium Product Description
6.14.5 Topfond Recent Developments
6.15 Zhejiang Hisun Pharmacutical
6.15.1 Zhejiang Hisun Pharmacutical Corporation Information
6.15.2 Zhejiang Hisun Pharmacutical Overview
6.15.3 Zhejiang Hisun Pharmacutical Atorvastatin Calcium Sales and Revenue in China Market (2016-2021)
6.15.4 Zhejiang Hisun Pharmacutical Atorvastatin Calcium Product Description
6.15.5 Zhejiang Hisun Pharmacutical Recent Developments
6.16 Zhejiang Hongyuan Pharmaceutical
6.16.1 Zhejiang Hongyuan Pharmaceutical Corporation Information
6.16.2 Zhejiang Hongyuan Pharmaceutical Overview
6.16.3 Zhejiang Hongyuan Pharmaceutical Atorvastatin Calcium Sales and Revenue in China Market (2016-2021)
6.16.4 Zhejiang Hongyuan Pharmaceutical Atorvastatin Calcium Product Description
6.16.5 Zhejiang Hongyuan Pharmaceutical Recent Developments
6.17 Hubei Yitai Pharmaceutical
6.17.1 Hubei Yitai Pharmaceutical Corporation Information
6.17.2 Hubei Yitai Pharmaceutical Overview
6.17.3 Hubei Yitai Pharmaceutical Atorvastatin Calcium Sales and Revenue in China Market (2016-2021)
6.17.4 Hubei Yitai Pharmaceutical Atorvastatin Calcium Product Description
6.17.5 Hubei Yitai Pharmaceutical Recent Developments
6.18 Jiangsu Hengrui Medicine
6.18.1 Jiangsu Hengrui Medicine Corporation Information
6.18.2 Jiangsu Hengrui Medicine Overview
6.18.3 Jiangsu Hengrui Medicine Atorvastatin Calcium Sales and Revenue in China Market (2016-2021)
6.18.4 Jiangsu Hengrui Medicine Atorvastatin Calcium Product Description
6.18.5 Jiangsu Hengrui Medicine Recent Developments
7 China Atorvastatin Calcium Production Capacity, Analysis
7.1 China Atorvastatin Calcium Production Capacity, 2016-2027
7.2 Atorvastatin Calcium Production Capacity of Key Manufacturers in China Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Atorvastatin Calcium Supply Chain Analysis
9.1 Atorvastatin Calcium Industry Value Chain
9.2 Atorvastatin Calcium Upstream Market
9.3 Atorvastatin Calcium Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Atorvastatin Calcium Distributors and Sales Agents in China Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of Tables
Table 1. Key Players of Atorvastatin Calcium in China Market
Table 2. Top Atorvastatin Calcium Players in China Market, Ranking by Revenue (2019)
Table 3. China Atorvastatin Calcium Revenue by Companies, (US$, Mn), 2016-2021
Table 4. China Atorvastatin Calcium Revenue Share by Companies, 2016-2021
Table 5. China Atorvastatin Calcium Sales by Companies, (MT), 2016-2021
Table 6. China Atorvastatin Calcium Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Atorvastatin Calcium Price (2016-2021) & (K USD/MT)
Table 8. Manufacturers Atorvastatin Calcium Product Type
Table 9. List of Tier 1 Atorvastatin Calcium Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Atorvastatin Calcium Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of Chemical Synthesis
Table 12. Major Manufacturers of Biocatalysis
Table 13. By Type - China Atorvastatin Calcium Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - China Atorvastatin Calcium Revenue (US$, Mn), 2016-2021
Table 15. By Type - China Atorvastatin Calcium Revenue (US$, Mn), 2022-2027
Table 16. By Type - China Atorvastatin Calcium Sales (MT), 2016-2021
Table 17. By Type - China Atorvastatin Calcium Sales (MT), 2022-2027
Table 18. By Application - China Atorvastatin Calcium Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - China Atorvastatin Calcium Revenue (US$, Mn), 2016-2021
Table 20. By Application - China Atorvastatin Calcium Revenue (US$, Mn), 2022-2027
Table 21. By Application - China Atorvastatin Calcium Sales (MT), 2016-2021
Table 22. By Application - China Atorvastatin Calcium Sales (MT), 2022-2027
Table 23. Pfizer Corporation Information
Table 24. Pfizer Description and Major Businesses
Table 25. Pfizer Atorvastatin Calcium Sales (MT), Revenue (US$, Mn) and Gross Margin (K USD/MT) (2016-2021)
Table 26. Pfizer Atorvastatin Calcium Product
Table 27. Pfizer Recent Developments
Table 28. DSM Sinochem Pharmaceuticals Corporation Information
Table 29. DSM Sinochem Pharmaceuticals Description and Major Businesses
Table 30. DSM Sinochem Pharmaceuticals Atorvastatin Calcium Sales (MT), Revenue (US$, Mn) and Gross Margin (K USD/MT) (2016-2021)
Table 31. DSM Sinochem Pharmaceuticals Atorvastatin Calcium Product
Table 32. DSM Sinochem Pharmaceuticals Recent Developments
Table 33. Ind-Swift Corporation Information
Table 34. Ind-Swift Description and Major Businesses
Table 35. Ind-Swift Atorvastatin Calcium Sales (MT), Revenue (US$, Mn) and Gross Margin (K USD/MT) (2016-2021)
Table 36. Ind-Swift Atorvastatin Calcium Product
Table 37. Ind-Swift Recent Developments
Table 38. Cadila Pharmaceuticals Corporation Information
Table 39. Cadila Pharmaceuticals Description and Major Businesses
Table 40. Cadila Pharmaceuticals Atorvastatin Calcium Sales (MT), Revenue (US$, Mn) and Gross Margin (K USD/MT) (2016-2021)
Table 41. Cadila Pharmaceuticals Atorvastatin Calcium Product
Table 42. Cadila Pharmaceuticals Recent Developments
Table 43. Morepen Corporation Information
Table 44. Morepen Description and Major Businesses
Table 45. Morepen Atorvastatin Calcium Sales (MT), Revenue (US$, Mn) and Gross Margin (K USD/MT) (2016-2021)
Table 46. Morepen Atorvastatin Calcium Product
Table 47. Morepen Recent Developments
Table 48. Sun Pharmaceutical Industries Corporation Information
Table 49. Sun Pharmaceutical Industries Description and Major Businesses
Table 50. Sun Pharmaceutical Industries Atorvastatin Calcium Sales (MT), Revenue (US$, Mn) and Gross Margin (K USD/MT) (2016-2021)
Table 51. Sun Pharmaceutical Industries Atorvastatin Calcium Product
Table 52. Sun Pharmaceutical Industries Recent Developments
Table 53. MSN Laboratories Corporation Information
Table 54. MSN Laboratories Description and Major Businesses
Table 55. MSN Laboratories Atorvastatin Calcium Sales (MT), Revenue (US$, Mn) and Gross Margin (K USD/MT) (2016-2021)
Table 56. MSN Laboratories Atorvastatin Calcium Product
Table 57. MSN Laboratories Recent Developments
Table 58. Dr. Reddy's Corporation Information
Table 59. Dr. Reddy's Description and Major Businesses
Table 60. Dr. Reddy's Atorvastatin Calcium Sales (MT), Revenue (US$, Mn) and Gross Margin (K USD/MT) (2016-2021)
Table 61. Dr. Reddy's Atorvastatin Calcium Product
Table 62. Dr. Reddy's Recent Developments
Table 63. Teva Pharmaceutical Industries Corporation Information
Table 64. Teva Pharmaceutical Industries Description and Major Businesses
Table 65. Teva Pharmaceutical Industries Atorvastatin Calcium Sales (MT), Revenue (US$, Mn) and Gross Margin (K USD/MT) (2016-2021)
Table 66. Teva Pharmaceutical Industries Atorvastatin Calcium Product
Table 67. Teva Pharmaceutical Industries Recent Developments
Table 68. Apotex Pharmachem Corporation Information
Table 69. Apotex Pharmachem Description and Major Businesses
Table 70. Apotex Pharmachem Atorvastatin Calcium Sales (MT), Revenue (US$, Mn) and Gross Margin (K USD/MT) (2016-2021)
Table 71. Apotex Pharmachem Atorvastatin Calcium Product
Table 72. Apotex Pharmachem Recent Developments
Table 73. Zheijang Neo-Dankon Pharmaceutical Corporation Information
Table 74. Zheijang Neo-Dankon Pharmaceutical Description and Major Businesses
Table 75. Zheijang Neo-Dankon Pharmaceutical Atorvastatin Calcium Sales (MT), Revenue (US$, Mn) and Gross Margin (K USD/MT) (2016-2021)
Table 76. Zheijang Neo-Dankon Pharmaceutical Atorvastatin Calcium Product
Table 77. Zheijang Neo-Dankon Pharmaceutical Recent Developments
Table 78. Ningbo Menovo Pharmaceuticals Group Corporation Information
Table 79. Ningbo Menovo Pharmaceuticals Group Description and Major Businesses
Table 80. Ningbo Menovo Pharmaceuticals Group Atorvastatin Calcium Sales (MT), Revenue (US$, Mn) and Gross Margin (K USD/MT) (2016-2021)
Table 81. Ningbo Menovo Pharmaceuticals Group Atorvastatin Calcium Product
Table 82. Ningbo Menovo Pharmaceuticals Group Recent Developments
Table 83. Jialin Pharmaceutical Corporation Information
Table 84. Jialin Pharmaceutical Description and Major Businesses
Table 85. Jialin Pharmaceutical Atorvastatin Calcium Sales (MT), Revenue (US$, Mn) and Gross Margin (K USD/MT) (2016-2021)
Table 86. Jialin Pharmaceutical Atorvastatin Calcium Product
Table 87. Jialin Pharmaceutical Recent Developments
Table 88. Topfond Corporation Information
Table 89. Topfond Description and Major Businesses
Table 90. Topfond Atorvastatin Calcium Sales (MT), Revenue (US$, Mn) and Gross Margin (K USD/MT) (2016-2021)
Table 91. Topfond Atorvastatin Calcium Product
Table 92. Topfond Recent Developments
Table 93. Zhejiang Hisun Pharmacutical Corporation Information
Table 94. Zhejiang Hisun Pharmacutical Description and Major Businesses
Table 95. Zhejiang Hisun Pharmacutical Atorvastatin Calcium Sales (MT), Revenue (US$, Mn) and Gross Margin (K USD/MT) (2016-2021)
Table 96. Zhejiang Hisun Pharmacutical Atorvastatin Calcium Product
Table 97. Zhejiang Hisun Pharmacutical Recent Developments
Table 98. Zhejiang Hongyuan Pharmaceutical Corporation Information
Table 99. Zhejiang Hongyuan Pharmaceutical Description and Major Businesses
Table 100. Zhejiang Hongyuan Pharmaceutical Atorvastatin Calcium Sales (MT), Revenue (US$, Mn) and Gross Margin (K USD/MT) (2016-2021)
Table 101. Zhejiang Hongyuan Pharmaceutical Atorvastatin Calcium Product
Table 102. Zhejiang Hongyuan Pharmaceutical Recent Developments
Table 103. Hubei Yitai Pharmaceutical Corporation Information
Table 104. Hubei Yitai Pharmaceutical Description and Major Businesses
Table 105. Hubei Yitai Pharmaceutical Atorvastatin Calcium Sales (MT), Revenue (US$, Mn) and Gross Margin (K USD/MT) (2016-2021)
Table 106. Hubei Yitai Pharmaceutical Atorvastatin Calcium Product
Table 107. Hubei Yitai Pharmaceutical Recent Developments
Table 108. Jiangsu Hengrui Medicine Corporation Information
Table 109. Jiangsu Hengrui Medicine Description and Major Businesses
Table 110. Jiangsu Hengrui Medicine Atorvastatin Calcium Sales (MT), Revenue (US$, Mn) and Gross Margin (K USD/MT) (2016-2021)
Table 111. Jiangsu Hengrui Medicine Atorvastatin Calcium Product
Table 112. Jiangsu Hengrui Medicine Recent Developments
Table 113. Atorvastatin Calcium Production Capacity (MT) of Key Manufacturers in China Market, 2019-2021 (MT)
Table 114. China Atorvastatin Calcium Capacity Market Share of Key Manufacturers, 2019-2021
Table 115. Atorvastatin Calcium Market Opportunities & Trends in China Market
Table 116. Atorvastatin Calcium Market Drivers in China Market
Table 117. Atorvastatin Calcium Market Restraints in China Market
Table 118. Atorvastatin Calcium Raw Materials
Table 119. Atorvastatin Calcium Raw Materials Suppliers in China Market
Table 120. Typical Atorvastatin Calcium Downstream
Table 121. Atorvastatin Calcium Downstream Clients in China Market
Table 122. Atorvastatin Calcium Distributors and Sales Agents in China Market
List of Figures
Figure 1. Atorvastatin Calcium Product Picture
Figure 2. Atorvastatin Calcium Segment by Type
Figure 3. Atorvastatin Calcium Segment by Application
Figure 4. China Atorvastatin Calcium Market Overview: 2020
Figure 5. China Atorvastatin Calcium Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. China Atorvastatin Calcium Revenue, 2016-2027 (US$, Mn)
Figure 7. Atorvastatin Calcium Sales in China Market: 2016-2027 (MT)
Figure 8. The Top 3 and 5 Players Market Share by Atorvastatin Calcium Revenue in 2020
Figure 9. Chemical Synthesis Product Picture
Figure 10. Biocatalysis Product Picture
Figure 11. By Type - China Atorvastatin Calcium Sales Market Share, 2016-2027
Figure 12. By Type - China Atorvastatin Calcium Revenue Market Share, 2016-2027
Figure 13. By Type - China Atorvastatin Calcium Price (K USD/MT), 2016-2027
Figure 14. Tablet (Including Dispersible Tablet and General Tablet)
Figure 15. Capsule
Figure 16. Others
Figure 17. By Application - China Atorvastatin Calcium Sales Market Share, 2016-2027
Figure 18. By Application - China Atorvastatin Calcium Revenue Market Share, 2016-2027
Figure 19. By Application - China Atorvastatin Calcium Price (K USD/MT), 2016-2027
Figure 20. Pfizer Atorvastatin Calcium Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 21. DSM Sinochem Pharmaceuticals Atorvastatin Calcium Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 22. Ind-Swift Atorvastatin Calcium Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. Cadila Pharmaceuticals Atorvastatin Calcium Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. Morepen Atorvastatin Calcium Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. Sun Pharmaceutical Industries Atorvastatin Calcium Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. MSN Laboratories Atorvastatin Calcium Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 27. Dr. Reddy's Atorvastatin Calcium Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 28. Teva Pharmaceutical Industries Atorvastatin Calcium Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 29. Apotex Pharmachem Atorvastatin Calcium Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 30. Zheijang Neo-Dankon Pharmaceutical Atorvastatin Calcium Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 31. Ningbo Menovo Pharmaceuticals Group Atorvastatin Calcium Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 32. Jialin Pharmaceutical Atorvastatin Calcium Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 33. Topfond Atorvastatin Calcium Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 34. Zhejiang Hisun Pharmacutical Atorvastatin Calcium Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 35. Zhejiang Hongyuan Pharmaceutical Atorvastatin Calcium Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 36. Hubei Yitai Pharmaceutical Atorvastatin Calcium Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 37. Jiangsu Hengrui Medicine Atorvastatin Calcium Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. China Atorvastatin Calcium Production Capacity (MT), 2016-2027
Figure 39. Atorvastatin Calcium Industry Value Chain
Figure 40. Marketing Channels

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Digoxin Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 75

According to our LPI (LP Information) latest study, the global Digoxin market size was valued at US$ 59 million in 2023. With growing demand in downstream market, the Digoxin is forecast to a readjusted size of US$ 73 million by 2030 with a CAGR of 3.2% during review period. The research report highlights the growth potential of the global Digoxin market. Digoxin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain op......

Global Heart Failure Drugs Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 116

According to our LPI (LP Information) latest study, the global Heart Failure Drugs market size was valued at US$ million in 2023. With growing demand in downstream market, the Heart Failure Drugs is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Heart Failure Drugs market. Heart Failure Drugs are expected to show stable growth in the future market. However, product differentiatio......

Global Atorvastatin Calcium Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 138

According to our LPI (LP Information) latest study, the global Atorvastatin Calcium market size was valued at US$ 214.2 million in 2023. With growing demand in downstream market, the Atorvastatin Calcium is forecast to a readjusted size of US$ 362 million by 2030 with a CAGR of 7.8% during review period. The research report highlights the growth potential of the global Atorvastatin Calcium market. Atorvastatin Calcium are expected to show stable growth in the future market. However, prod......

Global Rosuvastatin Calcium Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 139

According to our LPI (LP Information) latest study, the global Rosuvastatin Calcium market size was valued at US$ 514.3 million in 2023. With growing demand in downstream market, the Rosuvastatin Calcium is forecast to a readjusted size of US$ 683.6 million by 2030 with a CAGR of 4.1% during review period. The research report highlights the growth potential of the global Rosuvastatin Calcium market. Rosuvastatin Calcium are expected to show stable growth in the future market. However, pr......

Global Atorvastatin Calcium Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 133

According to our (Global Info Research) latest study, the global Atorvastatin Calcium market size was valued at USD 225.3 million in 2023 and is forecast to a readjusted size of USD 366.1 million by 2030 with a CAGR of 7.2% during review period. Atorvastatin calcium is a pharmaceutical raw material in the production of atorvastatin calcium drug (trade name: Lipitor), which is a prescription medicine that lowers the LDL cholesterol and triglycerides in the blood and can raise HDL choleste......

Global Rosuvastatin Calcium Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 132

According to our (Global Info Research) latest study, the global Rosuvastatin Calcium market size was valued at USD 540.9 million in 2023 and is forecast to a readjusted size of USD 703.6 million by 2030 with a CAGR of 3.8% during review period. Rosuvastatin calcium (CAS 147098-20-2, molecular formula being C44H54CaF2N6O12S2) is the active pharmaceutical ingredient for the once-a-day dyslipidaemia treatment Crestor, it is one approved API which can be used to reduce the risk of heart att......

Cilostazol - Global Market Insights and Sales Trends 2024

Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 118

The global Cilostazol market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Cilostazol in various end use industries. The expanding demands from the Hospital, Clinic and Others,, are propelling Cilostazol market. Injection Cilostazol, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Freeze-dried P......

Rosuvastatin - Global Market Insights and Sales Trends 2024

Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 110

Rosuvastatin medication is a statin that is used to lower bad cholesterol and prevent cardiovascular disease. It works by blocking an enzyme in the liver that makes cholesterol. It is taken by mouth and should be used together with dietary changes, exercise, and weight loss. It may also raise good cholesterol and lower triglycerides. It is sold under the brand name Crestor among others. It may be used when other statins have not worked well. The global Rosuvastatin market size is expected......

Global Congestive Heart Failure Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 19-Dec-2023        Price: US 3380 Onwards        Pages: 123

Market Overview of Global Congestive Heart Failure Drugs market: According to our latest research, the global Congestive Heart Failure Drugs market looks promising in the next 5 years. As of 2022, the global Congestive Heart Failure Drugs market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Congestive heart failure is a serious and complex condition in which the heart muscles are either dam......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs